Weekly Picks: 🇺🇸 A Hedge Against US Government Shutdown And 2 More Picks

Each week our analysts hand pick their favourite Narratives.

Narratives are a game-changing way for investors to make smart decisions on their stocks. A narrative always has 3 parts: a story, a forecast and a fair value . You can create one yourself in 3 minutes or you can select one from our thriving community .

This week’s picks cover: 

• 📦 How UPS plans to cut costs and automate its way back to profitability
• 💊 Why Paradigm Biopharma could soar if its osteoarthritis drug wins FDA approval
• 🥇 How Barrick Mining offers a hedge against U.S. fiscal chaos

💡 Why we like it: NVF takes a balanced, fundamentals-first view of UPS’s turnaround story, highlighting both the risks and the potential upside of its bold “ Efficiency Reimagined ” overhaul.

💡 Why we like it: This narrative outlines the transformative potential of Zilosul’s FDA approval while grounding the analysis in realistic assumptions around risk, valuation, and execution.

💡 Why we like it: The author keeps the analysis tight and timely, blending macro context with clear valuation logic to show how this stock has upside potential. 

What's next?

1. 🔔 Know when to act: Set the narrative valuations as your own fair value to know when to buy, hold or sell the stock.

2. 🤔 Get answers: Ask the author any questions in the comments section. Feel free to like as well to support their work.

3. ✨ Discover more Narratives: There are hundreds of other insightful stock narratives on our Community page .

4. ✍️ Build an audience: Have your narrative seen by millions of investors, simply meet our Featuring criteria to go into the running!

Disclaimer

Simply Wall St analyst Michael Paige and Simply Wall St have no position in any of the companies mentioned. These narratives are general in nature and explore scenarios and estimates created by the authors. These narratives do not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company’s future performance and are exploratory in the ideas they cover. The fair value estimate’s are estimations only, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author’s analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Simply Wall St analyst Michael Paige and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.